How many injections of ceftriaxone (Ceftriaxone) are typically recommended for a child with sinusitis or otitis media?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ceftriaxone Dosing for Pediatric Sinusitis and Otitis Media

A single intramuscular or intravenous dose of ceftriaxone 50 mg/kg (maximum 1 gram) is the recommended regimen for children with sinusitis or otitis media when parenteral therapy is indicated. 1, 2

When Ceftriaxone is Indicated

Ceftriaxone should be reserved for specific clinical scenarios rather than routine first-line treatment:

  • Children who are vomiting or unable to tolerate oral medication 3, 1
  • Children unlikely to be adherent to initial oral antibiotic doses 1
  • Children who have failed 72 hours of appropriate oral antibiotic therapy 3, 1

The three major bacterial pathogens (Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis) are susceptible to ceftriaxone in 95-100% of cases. 3, 1

Number of Injections Required

Typically, only ONE injection is needed. 1, 2, 4, 5

Post-Injection Management Algorithm:

At 24 hours after the injection:

  • If clinical improvement occurs: Switch to oral antibiotics (high-dose amoxicillin-clavulanate 90 mg/kg/day of amoxicillin component) to complete a total 10-14 day treatment course 3, 1

  • If still significantly febrile or symptomatic: Additional parenteral ceftriaxone doses may be required before transitioning to oral therapy 3, 1

For moderate disease in children who have received recent antibiotics, guidelines suggest ceftriaxone 50 mg/kg per day for 5 days as an alternative regimen. 3 However, the single-dose approach with transition to oral therapy is more commonly recommended and supported by high-quality evidence.

Supporting Evidence

Multiple randomized controlled trials demonstrate that a single 50 mg/kg dose of ceftriaxone is as effective as 10 days of oral antibiotics for acute otitis media, with success rates of 91% comparable to amoxicillin. 5, 6, 7, 8 A Chinese multicenter trial showed 97.17% cure/improvement rates with single-dose ceftriaxone versus 90.57% with 10-day amoxicillin (P < 0.05). 4

Critical Caveats

Reassessment is mandatory at 72 hours if the child was started on oral antibiotics, or at 24 hours if ceftriaxone was given. 3, 1 Failure to improve warrants either switching antibiotics or reevaluation for complications.

Red flags requiring immediate imaging and specialist consultation include: 1

  • Periorbital or orbital swelling with proptosis
  • Impaired extraocular muscle function
  • Severe headache with photophobia
  • Seizures or focal neurologic findings

Neonatal considerations: Ceftriaxone is contraindicated in neonates ≤28 days requiring calcium-containing IV solutions due to precipitation risk. 2 In neonates where ceftriaxone is necessary, administer over 60 minutes (not 30 minutes as in older children) to reduce bilirubin encephalopathy risk. 9, 2

References

Guideline

Ceftriaxone Dosing for Pediatric Sinusitis and Otitis Media

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Intramuscular ceftriaxone in comparison with oral amoxicillin-clavulanate for the treatment of acute otitis media in infants and children.

Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2004

Guideline

Pediatric Dosing of Ceftriaxone

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.